Eli Lilly announced clinical trial results this week for a daily pill to treat obesity and diabetes. Its name is absolutely ...

Work has begun in the UK on developing new tests that will spot if someone has “fat genes”. The project, which seeks to ...

Within Novo Nordisk's comprehensive business update ... extend and sustain the obesity franchise as new competitors like Eli Lilly, Pfizer, MSD, and Boehringer Ingelheim/Zealand Pharma start ...

STAC-BBB shows widespread neuronal transduction across all cortical regions, according to Sangamo. Sangamo Therapeutics was hit hard by the loss of Pfizer as a partner at the end of last year, but ...